effect
ayurved
polyherbominer
formul
kumarabharana
rasa
kr
manag
chronic
tonsil
tundikeri
children
assess
studi
clinic
studi
doublearm
studi
preand
posttest
design
outpati
level
tertiari
ayurveda
hospit
attach
teach
institut
locat
district
headquart
southern
india
patient
n
chronic
tonsil
satisfi
diagnost
criteria
age
year
select
outpati
depart
kaumarbhritya
sdm
colleg
ayurveda
hospit
hassan
among
patient
treat
kumarabharana
rasa
tablet
form
dose
mg
daili
day
group
patient
treat
godhuma
vati
placebo
dose
mg
daili
day
group
b
group
madhu
anupana
advis
complet
day
treatment
patient
assess
follow
day
anoth
investig
took
place
day
later
statist
signific
effect
p
reduct
sign
symptom
chronic
tonsil
kr
treatment
observ
result
indic
kumarabharana
rasa
amelior
effect
reduc
sign
symptom
chronic
tonsil
chronic
tonsil
cht
one
common
otolaryngolog
diseas
cht
rare
infant
older
peopl
young
children
tonsil
one
recurr
upper
respiratori
tract
infect
cht
highli
preval
diseas
pediatr
age
group
peak
year
age
declin
gener
practic
children
frequent
visit
recurr
throat
problem
incid
diseas
account
visit
pediatrician
children
cht
experi
discomfort
diseas
also
impact
social
emot
financi
aspect
famili
member
tonsil
infect
tonsil
despit
high
preval
etiolog
cht
remain
indistinct
surfac
deep
bacteri
flora
chronic
inflam
tonsil
consist
abund
probabl
pathogen
aerob
anaerob
bacteria
primarili
streptococc
origin
tonsil
part
immun
system
therefor
due
decreas
immun
tonsil
incompet
help
immun
system
actual
becom
sourc
recurr
infect
current
treatment
option
cht
tonsillectomi
ultim
solut
gener
accept
criteria
tonsillectomi
least
three
seven
episod
tonsil
per
year
spite
medic
therapi
intern
consensu
ayurved
thought
tonsil
correl
tundikeri
one
urdhvajatrugata
roga
diseas
head
neck
mention
talugata
roga
diseas
palat
well
kanthagata
roga
diseas
throat
ayurveda
explain
caus
vitiat
imbal
dosha
bodili
humor
ie
vata
pitta
kapha
mainli
derang
kapha
rakta
blood
preced
impair
digest
capac
mandagnivishamagni
obstruct
channel
sroto
avarodha
name
annavaha
srota
gastrointestin
tract
pranavaha
srota
respiratori
tract
manifest
difficulti
swallow
mouth
breath
choke
spell
night
etc
present
studi
conduct
explor
efficaci
kumarabharana
rasa
kr
manag
chronic
tonsil
children
kr
combin
action
vitiat
dosha
due
antiinflammatori
antimicrobi
immunomodulatori
rejuvin
effect
studi
openlabel
doublearm
set
preand
posttest
design
children
present
symptom
chronic
tonsil
tundikeri
ie
kathina
shotha
enlarg
tonsil
ragatwa
hyperemia
galoparodha
dysphagia
mukha
daurgandhya
halitosi
lasikagranthi
vriddhi
enlarg
lymph
node
jwara
fever
select
regist
kaumarabhritya
ayurved
pediatr
outpati
depart
sdm
colleg
ayurveda
hospit
hassan
june
decemb
initi
studi
ethic
clearanc
obtain
institut
ethic
committe
sdm
colleg
ayurveda
hospit
hassan
iec
date
written
inform
consent
taken
parent
studi
particip
studyrel
procedur
perform
inclus
criteria
children
sex
year
age
repeat
attack
tonsil
chronic
infect
past
year
exclus
criteria
patient
acut
tonsil
peritonsillar
abscess
tonsillar
cyst
tonsillolith
system
disord
patient
taken
system
steroid
andor
antibiot
past
week
compound
drug
compris
bhasma
purifi
calx
swarna
gold
rajata
silver
pravala
coral
churna
powder
yastimadhu
glycyrrhiza
glabra
linn
amlaki
emblica
officinali
gaertn
ashwagandha
withania
somnifera
dunal
sunthi
zingib
officinal
rosc
pippali
piper
longum
linn
haritaki
terminalia
chebula
retz
vacha
acoru
calamu
linn
drug
process
swarasa
extract
juic
guduchi
tinospora
cordifolia
mier
ex
hook
f
thom
brahmi
centella
asiatica
linn
tulsi
ocimum
tenuiflorum
linn
separ
prepar
tablet
form
wheat
powder
process
prepar
tablet
form
raw
drug
obtain
sdm
pharmaci
udupi
authent
depart
dravyaguna
sdm
colleg
ayurveda
hospit
hassan
medicin
prepar
teach
pharmaci
sdm
colleg
ayurveda
hospit
hassan
tablet
mg
prepar
preserv
airtight
properli
label
plastic
bottl
contain
tablet
total
patient
screen
chronic
tonsil
among
patient
enrol
studi
fulfil
inclus
exclus
criteria
conveni
sampl
techniqu
adopt
patient
studi
group
kr
control
group
godhuma
vati
patient
studi
group
treat
kr
tablet
form
dose
mg
daili
day
patient
control
group
treat
godhuma
vati
tablet
form
dose
mg
daili
day
parent
advis
crush
tablet
powder
give
child
use
honey
anupana
vehicl
drug
administr
food
morn
group
assess
sign
symptom
done
day
day
sever
assess
grade
absenc
sever
symptom
kathina
shotha
enlarg
tonsil
e
enlarg
enlarg
within
anterior
pillar
enlarg
within
posterior
pillar
enlarg
beyond
pillar
kiss
tonsil
sleep
apnea
ragatwa
hyperemia
e
hyperemia
hyperemia
tonsil
surfac
pinkish
appear
pillar
reddish
appear
surround
reddish
appear
surround
pharynx
galoparodha
dysphagia
e
pain
swallow
pain
swallow
solid
food
substanc
pain
swallow
semisolid
food
substanc
pain
swallow
liquid
food
substanc
continu
painun
swallow
mukha
daurgandhya
halitosi
e
halitosi
foul
breath
experienc
patient
foul
breath
experienc
patient
friendspar
foul
breath
experienc
group
surround
peopl
foul
breath
experienc
soon
patient
open
mouth
lasikagranthi
vriddhi
enlarg
lymph
node
e
palpabl
lymph
node
palpabl
lymph
node
unilateralwarm
palpabl
lymph
node
bilateralsoftfluctu
palpabl
lymph
node
bilater
hard
palpabl
lymph
node
bilater
tender
jwara
fever
measur
accord
degre
fahrenheit
normal
fahrenheit
assess
base
routin
laboratori
blood
investig
e
hemoglobin
hb
total
leukocyt
count
tlc
neutrophil
lymphocyt
eosinophil
erythrocyt
sediment
rate
esr
perform
day
day
statist
analysi
statist
packag
social
scienc
spss
version
ssp
inc
chicago
il
usa
use
independ
sampl
test
mannwhitney
u
test
betweensubject
design
pair
sampl
test
wilcoxon
test
withinsubject
design
done
present
studi
patient
regist
particip
complet
studi
sociodemograph
profil
particip
show
male
rest
femal
age
group
year
consist
particip
respect
major
particip
belong
hindu
religion
socioeconom
assess
reveal
belong
lowermiddl
class
follow
uppermiddl
class
strata
prakriti
genet
phenotyp
yield
major
pittakapha
prakriti
mix
diet
consum
particip
sleep
pattern
show
particip
slept
around
hoursday
disturb
sleep
normal
sleep
famili
histori
particip
highlight
posit
famili
histori
chronic
tonsil
durat
tonsil
reveal
particip
durat
tonsil
period
year
durat
tonsil
period
year
durat
onset
tonsil
period
year
less
poor
oral
hygien
observ
among
particip
good
oral
hygien
chief
complaint
report
throat
pain
among
patient
difficulti
deglutit
patient
halitosi
patient
fever
patient
breath
difficulti
among
patient
complaint
mouth
breath
patient
report
jugulodigastr
lymphadenopathi
enlarg
tonsil
clinic
diagnosi
reveal
patient
chronic
parenchymat
tonsil
patient
chronic
follicular
tonsil
diagnos
chronic
fibroid
tonsil
within
group
wilcoxon
sign
rank
test
statist
signific
p
sign
symptom
chronic
tonsil
found
kr
intervent
noth
signific
observ
godhuma
vati
intervent
tabl
howev
group
mann
whitney
u
test
effect
kr
sign
symptom
chronic
tonsil
found
signific
p
tabl
routin
laboratori
blood
investig
assess
within
kr
studi
group
show
statist
signific
p
hb
tlc
lymphocyt
esr
wherea
godhuma
vati
placebo
nonsignific
tabl
comparison
effect
kr
studi
group
godhuma
vati
placebo
group
laboratori
investig
fever
nonsignific
p
detail
tabl
cht
inflamm
tonsil
caus
microbi
infect
symptom
usual
mild
often
relat
common
cold
streptococc
infect
tonsil
often
swell
becom
coat
throat
sore
patient
temperatur
foulsmel
breath
may
feel
quit
ill
therefor
drug
antiinflammatori
immunomodulatori
effect
may
use
treatment
cht
ayurveda
well
recent
experiment
result
indic
ingredi
polyherbominer
formul
kr
antiinflammatori
antimicrobi
immunomodulatori
effect
substanti
clinic
observ
among
tonsil
patient
key
ingredi
metal
bhasma
purifi
calx
like
swarna
bhasma
prepar
inciner
gold
process
herbal
prepar
swarna
bhasma
promot
immun
phagocytosi
gold
polyherb
formul
found
increas
vital
immun
clinic
applic
swarna
bhasma
gold
salt
ayurveda
known
rejuven
immunomodul
chronic
diseas
gold
nanoparticl
signific
applic
target
drug
deliveri
swarna
bhasma
contain
gold
particl
size
rang
nanoparticl
recent
studi
show
swarna
bhasma
contain
gold
also
sever
microel
fe
al
cu
zn
co
mg
ca
pb
etc
anim
model
studi
show
swarna
bhasmatr
anim
significantli
increas
superoxid
dismutas
catalas
activ
respons
reduc
free
radic
concentr
bodi
antioxid
effect
swarna
bhasma
consid
one
mechan
immunomodulatori
mode
action
formul
rajata
bhasma
silver
calx
nanoparticul
complex
silver
along
sn
cd
mg
k
na
ca
p
si
al
cl
ar
fe
cu
ba
hg
cr
recent
scientif
trend
indic
emerg
metal
silver
form
silver
nanoparticl
potenti
antimicrobi
agent
special
import
sever
pathogen
bacteria
develop
resist
variou
antibiot
herbal
compon
like
amalaki
phylanthu
embellica
guduchi
tinospora
cordifolia
nourish
rejuvin
properti
experiment
studi
reveal
immunostimul
activ
combat
sepsi
anim
vacha
sunthi
pippali
ashwagandha
yastimadhu
amalaki
haritaki
immunomodulatori
properti
pippali
import
drug
treatment
cough
common
cold
use
digest
activ
principl
piperin
known
bioenhanc
antiinflammatori
effect
yasthimadhu
promin
rasayana
known
immunomodulatori
antiinflammatori
antiallerg
antivir
activ
also
enhanc
permeabl
drug
deliveri
system
yastimadhu
glycerrhiza
glabra
also
cytoprotect
demulc
effect
popular
home
remedi
minor
throat
infect
biolog
activ
substanc
liquoric
root
includ
glycyrrhiz
acid
gl
aglycon
ga
phenol
compound
oligosaccharid
polysaccharid
lipid
sterin
etc
mani
research
suggest
effect
product
interferon
ifn
cytokin
might
one
mechan
involv
antiinfect
process
recent
glycyrrhizin
found
activ
inhibit
replic
sever
acut
respiratori
syndrom
sar
associ
viru
also
influenza
virusinfect
cell
gl
also
report
modulatori
effect
complement
system
report
indic
gl
block
distal
stage
complement
cascad
suggest
might
role
prevent
tissu
injuri
chronic
hepat
also
autoimmun
inflammatori
diseas
chemic
modif
gl
ga
tri
signific
improv
antiinflammatori
antiallerg
antiulc
activ
observ
observ
indic
immunemodul
biolog
respons
modifi
activ
associ
gl
tinospora
cordifolia
tc
known
immunomodulatori
cytoprotect
activ
quaternari
alkaloid
biotherapeut
diterpen
glucosid
tc
syringin
cordiol
cordiosid
coriofoliosid
show
immunopotenti
activ
research
work
conduct
berberin
jatrorrhizin
tinosporasid
columbin
show
possibl
mechan
immunomodulatori
activ
activ
macrophag
lead
increas
granulocyteemacrophag
colonystimul
factor
gmcsf
leukocytosi
improv
neutrophil
function
tc
also
inhibit
convertas
classic
complement
pathway
research
polysaccharid
adglucan
deriv
tc
show
activ
nuclear
killer
nk
cell
complement
system
pathway
cytokin
coupl
low
nitric
oxid
synthesi
aswagandha
shown
promis
immunomodulatori
effect
inflammatori
experiment
model
sunthi
zingib
officinali
antiinflammatori
properti
inhibit
lpsinduc
nfkb
activ
prevent
degrad
ikba
well
phosphoryl
sapkjnk
mapk
associ
decreas
express
induc
nitric
oxid
synthas
ino
vacha
acoru
calamu
report
inhibitori
effect
mast
celldepend
anaphylact
reaction
allerg
reaction
respiratori
tract
amla
phyllanthu
emblica
report
suppress
express
lpsinduc
proinflammatori
gene
ino
tnfa
raw
murin
macrophag
cell
dosedepend
manner
honey
known
enhanc
action
medicin
potenti
immunomodulatori
effect
thu
polyherbominer
formul
kr
combin
mechan
action
tonsil
reduc
number
attack
ayurved
perspect
control
imbal
dosha
thu
effect
reduc
sign
symptom
chronic
tonsil
howev
follow
revers
pharmacolog
perspect
find
scientif
evid
compon
inflamm
microbi
invas
via
multipl
mechan
mostli
immunomodul
discuss
futur
studi
kr
formul
along
line
revers
pharmacolog
may
produc
conclus
inform
combin
mechan
action
molecular
level
author
conflict
interest
declar
